Progress in the treatment of childhood leukemia has been curtailed by the limited success of drugs tested in immortal leukemia cells, which after years of culture in the laboratory have lost much of the properties characteristic of the original tumor that they were derived from. The expansion of patient leukemia cells in specialized mice offers an improved alternative for identification of new effective drugs, but this approach is cumbersome and slow limiting its broad applicability.